Literature DB >> 12398975

Importance of left atrial diameter and atrial fibrillatory frequency for conversion of persistent atrial fibrillation with oral flecainide.

Andreas Bollmann1, Karl-Heinz Binias, Ines Toepffer, Jochen Molling, Christoph Geller, Helmut U Klein.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 12398975     DOI： 10.1016/s0002-9149(02)02690-5

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN： 0002-9149            Impact factor:   2.778


× No keyword cloud information.
  10 in total

Review 1.  Atrial Remodelling : Role in Atrial Fibrillation Ablation.

Authors:  Herko Grubitzsch; Wilhelm Haverkamp
Journal:  J Atr Fibrillation       Date:  2012-12-16

2.  Predictors of successful cardioversion with vernakalant in patients with recent-onset atrial fibrillation.

Authors:  Natalia Mochalina; Tord Juhlin; Bertil Öhlin; Jonas Carlson; Fredrik Holmqvist; Pyotr G Platonov
Journal:  Ann Noninvasive Electrocardiol       Date:  2014-07-09       Impact factor: 1.468

3.  Exponential distribution of long heart beat intervals during atrial fibrillation and their relevance for white noise behaviour in power spectrum.

Authors:  Thomas Hennig; Philipp Maass; Junichiro Hayano; Stefan Heinrichs
Journal:  J Biol Phys       Date:  2006-12-15       Impact factor: 1.365

4.  Pilot study: Noninvasive monitoring of oral flecainide's effects on atrial electrophysiology during persistent human atrial fibrillation using the surface electrocardiogram.

Authors:  Daniela Husser; Karl-Heinz Binias; Martin Stridh; Leif Sornmo; S Bertil Olsson; Jochen Molling; Christoph Geller; Helmut U Klein; Andreas Bollmann
Journal:  Ann Noninvasive Electrocardiol       Date:  2005-04       Impact factor: 1.468

5.  Chloroquine terminates stretch-induced atrial fibrillation more effectively than flecainide in the sheep heart.

Authors:  David Filgueiras-Rama; Raphael P Martins; Sergey Mironov; Masatoshi Yamazaki; Conrado J Calvo; Steve R Ennis; Krishna Bandaru; Sami F Noujaim; Jérôme Kalifa; Omer Berenfeld; José Jalife
Journal:  Circ Arrhythm Electrophysiol       Date:  2012-03-30

6.  A genotype-dependent intermediate ECG phenotype in patients with persistent lone atrial fibrillation genotype ECG-phenotype correlation in atrial fibrillation.

Authors:  Daniela Husser; Martin Stridh; Leif Sörnmo; Dan M Roden; Dawood Darbar; Andreas Bollmann
Journal:  Circ Arrhythm Electrophysiol       Date:  2009-02

7.  Frequency analysis of atrial fibrillation from the surface electrocardiogram.

Authors:  Daniela Husser; Martin Stridh; Leif Sornmo; S Bertil Olsson; Andreas Bollmann
Journal:  Indian Pacing Electrophysiol J       Date:  2004-07-01

8.  Effect of flecainide on atrial fibrillatory rate in a large animal model with induced atrial fibrillation.

Authors:  Eva Z Hesselkilde; Helena Carstensen; Maria M Haugaard; Jonas Carlson; Steen Pehrson; Thomas Jespersen; Rikke Buhl; Pyotr G Platonov
Journal:  BMC Cardiovasc Disord       Date:  2017-12-08       Impact factor: 2.298

9.  Personalized monitoring of electrical remodelling during atrial fibrillation progression via remote transmissions from implantable devices.

Authors:  José María Lillo-Castellano; Juan José González-Ferrer; Manuel Marina-Breysse; José Bautista Martínez-Ferrer; Luisa Pérez-Álvarez; Javier Alzueta; Juan Gabriel Martínez; Aníbal Rodríguez; Juan Carlos Rodríguez-Pérez; Ignasi Anguera; Xavier Viñolas; Arcadio García-Alberola; Jorge G Quintanilla; José Manuel Alfonso-Almazán; Javier García; Luis Borrego; Victoria Cañadas-Godoy; Nicasio Pérez-Castellano; Julián Pérez-Villacastín; Javier Jiménez-Díaz; José Jalife; David Filgueiras-Rama
Journal:  Europace       Date:  2020-05-01       Impact factor: 5.214

10.  Relationship between coarse F waves and thromboembolic events in patients with permanent atrial fibrillation.

Authors:  Yahya Kemal İçen; Hasan Koca; Hilmi Erdem Sümbül; Arafat Yıldırım; Fadime Koca; Abdullah Yıldırım; Mustafa Lutfullah Ardıc; Mükremin Coşkun; Mehmet Uğurlu; Mevlüt Koç
Journal:  J Arrhythm       Date:  2020-09-02
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.